<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00235183</url>
  </required_header>
  <id_info>
    <org_study_id>EFS plasma trial</org_study_id>
    <nct_id>NCT00235183</nct_id>
  </id_info>
  <brief_title>Plasma Transfusion in Liver Transplantation</brief_title>
  <official_title>Plasma Transfusion in Liver Transplantation : a Randomized, Double Blind, Multicenter Trial of Methylene Blue, Solvent/Detergent and Quarantined Plasma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Etablissement Français du Sang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Etablissement Français du Sang</source>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the clinical efficacy of three types of plasma secured on
      the viral level either by quarantine or by chemical treatment in patients undergoing liver
      transplantation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three types of plasma are transfused in bleeding patients undergoing liver transplantation:

        -  quarantined plasma,

        -  methylene blue treated plasma,

        -  solvent/detergent plasma. The main purpose is to show that the volume of methylene blue
           treated plasma consumed intraoperatively is equivalent to that of the 2 other types of
           plasma.

      In addition, the correction of coagulation abnormalities are studied.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Volume of transfused plasma during surgery</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>correction of coagulation abnormalities</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immediate and delayed adverse events</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Bleeding in Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Quarantined FFP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Quarantined FFP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methylene blue FFP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methylene blue FFP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Solvent detergent FFP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Solvent detergent FFP</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>plasma</intervention_name>
    <description>transfusion of more than 15 mL/Kg of plasma</description>
    <arm_group_label>Quarantined FFP</arm_group_label>
    <arm_group_label>Methylene blue FFP</arm_group_label>
    <arm_group_label>Solvent detergent FFP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18 yo and above

          -  consent is signed,

          -  liver transplantation is indicated,

          -  plasma is transfused

        Exclusion Criteria:

          -  multiorgan transplantation (except combined kidney and liver transplantation)

          -  allergy to methylene blue.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves Ozier, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Cochin, Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emmanuel Samain, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>hôpital Jean Minjoz, Besançon, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie - Christine Gillon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Paul Brousse, Villejuif, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Loïc Villalon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Pontchaillou</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>EFS</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2005</study_first_submitted>
  <study_first_submitted_qc>October 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 10, 2005</study_first_posted>
  <last_update_submitted>February 14, 2014</last_update_submitted>
  <last_update_submitted_qc>February 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>plasma</keyword>
  <keyword>bleeding</keyword>
  <keyword>liver transplantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylene Blue</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

